Berry Only Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Berry Only Inc
TickerHURA
CIK #0001498382
CUSIP898920103
SectorLife Sciences - Specialty Cleaning, Polishing And Sanitation Preparations
Address722 B Kingston Road, Toronto, ON M4E IR7
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Tuhura Biosciences Inc/NV 2025-11-10 1.5 M Exemption: 506(b) · Remaining: $1,500,000 · Duration: One year or less · Revenue: Decline to Disclose
Kintara Therapeutics Inc 2020-08-28 21.8 M Exemption: 506(b) · Remaining: $8,228,000 · Duration: One year or less · Commission: $3,000,000 · Revenue: Decline to Disclose
Delmar Pharmaceuticals Inc 2016-05-10 5.6 M Exemption: 506(b) · Remaining: Indefinite · Duration: One year or less · Commission: $110,472 · Finder's Fee: $120,080 · Revenue: No Revenues
CIK Filing 2011 - 2026
[0001498382] 10-K
[0001498382] 10-Q
[0001498382] 3
[0001498382] 4
[0001498382] 8-K
[0001498382] D
[0001498382] SC 13D
[0001498382] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Highbridge Capital Management LLC Tuhura Biosciences Inc/NV [2026-02-17] 0.0
Vanguard Group Inc Tuhura Biosciences Inc/NV [2025-07-29] 0.0
KP Biotech Group LLC Tuhura Biosciences Inc/NV [2024-10-25] 6.1
CA Patel F&F Investments LLC Tuhura Biosciences Inc/NV [2024-10-25] 6.1
Patel Vijay Tuhura Biosciences Inc/NV [2024-10-25] 26.7
Bianco James A Tuhura Biosciences Inc/NV [2024-10-25] 6.4
Theofilos Charles Steve Tuhura Biosciences Inc/NV [2024-10-25] 5.9
Patel Samir Rashmikant Tuhura Biosciences Inc/NV [2024-10-25] 5.8
Lind Global Fund II LP Kintara Therapeutics Inc [2022-04-20] 5.8
Pilkiewicz Carolyn Kintara Therapeutics Inc [2020-11-16] 0.15
Stern Adam K Kintara Therapeutics Inc [2020-08-28] 6.95
CVI Investments Inc Delmar Pharmaceuticals Inc [2019-08-23] 8.5
Intracoastal Capital LLC Delmar Pharmaceuticals Inc [2019-08-23] 0.99
Anson Funds Management LP Delmar Pharmaceuticals Inc [2019-06-13] 7.7
Intracoastal Capital LLC Delmar Pharmaceuticals Inc [2019-06-12] 4.99
Empery Asset Management LP Delmar Pharmaceuticals Inc [2019-06-05] 7.65
Sabby Management LLC Delmar Pharmaceuticals Inc [2018-11-26] 3.31
Intracoastal Capital LLC Delmar Pharmaceuticals Inc [2017-09-28] 4.99
Garner William J Delmar Pharmaceuticals Inc [2017-06-12] 4.5
Franklin Resources Inc Delmar Pharmaceuticals Inc [2017-05-10] 13.2
Sabby Management LLC Delmar Pharmaceuticals Inc [2017-04-13] 3.43
Garner William J Delmar Pharmaceuticals Inc [2016-05-10] 6.1
Garner William J Delmar Pharmaceuticals Inc [2014-10-31] 8.1
[2013-02-13] None
[2013-02-13] None
[2013-02-04] None
[2013-02-04] None
[2013-02-01] None
[2013-02-01] None
Form 3/4/5 Filer 2011 - 2026
TuHURA Biosciences Inc/NV
Bianco James A
Hoffman Robert
Tendler Craig
Ng George K
Manuso James S J
List Alan
Dearborn Dan
Yamashita Dennis
Patel Vijay
Brown Dennis M
Johnson Laura L
Toth Robert Joseph Jr
Favorito Tamara A
Praill Anthony Scott
Zarrabian Saiid
Murphy Keith
Liatos John
Bell John K
Cranston Lynda Sarah
Ferrara Napoleone
Mohr Erich
Bacha Jeffrey
Garner William J
Fuguet Howard K
Bahouth Donald G
Vollintine Raymond L
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Hoffman Robert
Options (Right to Buy) · derivative
2026-02-12 Grant 156,240 $0.00
Manuso James S J
Options (Right to Buy) · derivative
2026-02-12 Grant 156,240 $0.00
Ng George K
Options (Right to Buy) · derivative
2026-02-12 Grant 156,240 $0.00
Tendler Craig
Options (Right to Buy) · derivative
2026-02-12 Grant 156,240 $0.00
List Alan
Options (Right to Buy) · derivative
2026-02-12 Grant 156,240 $0.00
Bianco James A
Options (Right to Buy) · derivative
2026-01-06 Grant 610,332 $0.00
Dearborn Dan
Options (Right to Buy) · derivative
2026-01-06 Grant 273,696 $0.00
Bianco James A
Options (Right to Buy) · derivative
2025-12-12 Grant 3,414,891 $0.00
Dearborn Dan
Options (Right to Buy) · derivative
2025-12-12 Grant 1,531,367 $0.00
Tendler Craig
Options (Right to Buy) · derivative
2025-03-10 Grant 151,883 $0.00
Manuso James S J
Options (Right to Buy) · derivative
2025-01-02 Grant 59,590 $0.00
List Alan
Options (Right to Buy) · derivative
2025-01-02 Grant 51,275 $0.00
Ng George K
Options (Right to Buy) · derivative
2025-01-02 Grant 51,275 $0.00
Hoffman Robert
Options (Right to Buy) · derivative
2025-01-02 Grant 51,275 $0.00
Bianco James A
Options (Right to Buy) · derivative
2024-11-12 Grant 1,065,990 $0.00
Dearborn Dan
Options (Right to Buy) · derivative
2024-11-12 Grant 489,848 $0.00
Dearborn Dan
Options (Right to Buy) · derivative
2024-10-18 Grant 66,658 $0.00
Ng George K
Options (Right to Buy) · derivative
2024-10-18 Grant 13,553 $0.00
Bianco James A
Common Stock
2024-10-18 Grant 2,323,307 $0.00
Yamashita Dennis
Options (Right to Buy) · derivative
2024-10-18 Grant 196,790 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 89 9,459,306
2025-12-31 65 6,453,131
2025-09-30 70 6,147,197
2025-06-30 51 6,388,440
2025-03-31 28 3,655,056
2024-12-31 28 2,159,497
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 15,318 15,318
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 602 12,241
Gamma Investing LLC [2026-06-30] DFND 762 762
Farther Finance Advisors LLC [2026-06-30] SOLE 0 575
True Wealth Design LLC [2026-06-30] SOLE 0 167
IFP Advisors LLC [2026-06-30] SOLE 20 20
Fortitude Family Office LLC [2026-06-30] SOLE 2 2
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com